In the course of preparation of requirements to safety, effectiveness of medicines based on modern scientifically grounded information about the clinical experience of the use of fluezoxiglucose, l8F, used as a radiopharmaceutical diagnostic tool, the need for changes in the section "ATX code" was identified. This requirement is associated with the emergence of new information on the classification of these drugs to the ATC code with the goal of unifying instructions for the use of drugs fledosexiglucose, l8F the following information:
The section "ATX code" should be submitted in the following edition: V09IX04.